Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis (Q35997871)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis (English)

1 reference

Europe PubMed Central

11 August 2017

0 references

1 reference

based on heuristic

inferred from title

Franco Scaldaferri

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Valentina Petito

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Lucrezia Laterza

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Marco Pizzoferrato

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Gianluca Ianiro

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Francesco Paroni Sterbini

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Maurizio Sanguinetti

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

D Zambrano

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

L Fiore

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

L R Lopetuso

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

E Schiavoni

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

G Bruno

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

V Gerardi

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J Stojanovic

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Poscia

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

G Cammarota

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Gasbarrini

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

0 references

publication date

1 March 2016

1 reference

Europe PubMed Central

11 August 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

402-407

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Future for probiotic science in functional food and dietary supplement development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Molecular analysis of the gut microbiota of identical twins with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Letter: Faecal microbiota transplantation--not a one-size-fits-all approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Phylogenetic analysis of dysbiosis in ulcerative colitis during remission

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

The microbiome in inflammatory bowel disease: current status and the future ahead

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Mucosal flora in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Role of the microbiota in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Alterations in the gut microbiome of children with severe ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Characterization of bacterial community shift in human Ulcerative Colitis patients revealed by Illumina based 16S rRNA gene amplicon sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Duodenal infusion of donor feces for recurrent Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Therapeutic potential of fecal microbiota transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2015.12.040

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2015.12.040

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27109966%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35997871&oldid=1946628939"